Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data.
about
Review of studies mapping from quality of life or clinical measures to EQ-5D: an online databaseSystematic review of health state utility values for economic evaluation of colorectal cancerEconomic evaluations of psychosocial interventions in cancer: a systematic review.Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours - an analysis based on the CLARINET study.Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain.Six weeks of home enteral nutrition versus standard care after esophagectomy or total gastrectomy for cancer: study protocol for a randomized controlled trialLongitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients.Mapping onto Eq-5 D for patients in poor health.Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches.Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesotheliomaThe ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities.Two Year Clinical Outcomes of Total Hip Arthroplasty Are Not Dependent on Femoral Head Composition.Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature.Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L.A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility study.Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocolHealth-state utility values in breast cancer.Evaluation of content on EQ-5D as compared to disease-specific utility measures.Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature.Model-based cost-effectiveness analyses for the treatment of chronic lymphocytic leukaemia: a review of methods to model disease outcomes and estimate utility.The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments.Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients.Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes.Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.Mapping algorithms from QLQ-C30 to EQ-5D utilities: no firm ground to stand on yet.An assessment of the external validity of mapping QLQ-C30 to EQ-5D preferences.A systematic review and meta-analysis of utility estimates in melanoma.Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods.Cost-utility analysis of individual psychosocial support interventions for breast cancer patients in a randomized controlled study.Treating alcoholism reduces financial burden on care-givers and increases quality-adjusted life years.Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.Systematic review of health state utility values for acute myeloid leukemia.
P2860
Q27026613-4210C83F-5F0E-46C7-B74F-2D1D56FCEC8FQ28069968-F0ECB730-2908-4205-82ED-E02603538433Q30251940-1F5924AD-745D-4A46-971A-677000DDEA3CQ32173682-5068E398-30DE-4985-ADB1-6199F391EAF9Q33557934-19482B10-1141-41E0-BF48-7215F9CF4214Q33644019-F1269389-FEE2-44E2-A23B-5DE64FAB219DQ33689341-771401C3-9A53-44B3-B604-C0604901DF09Q34129848-62F818DE-4CF8-4C6F-9A94-0155C4BB6468Q34408145-0B0D0876-85F6-45CC-9212-29128AC5ADDEQ34455288-5E4CAFB2-25E2-464D-802F-34C17200719AQ34528309-09E0828E-8BC9-4628-B198-E738C299C08AQ35047438-47F75B1F-C973-4300-9FDA-20CA23818BB0Q35609091-030B6347-E8E5-4180-AC41-8D37578CE81AQ35783214-18CD961D-B3FF-413B-86E3-FF94BC35FF9CQ35887697-93F736D7-0569-40B9-BFC7-255AD1C569C1Q36070909-3B7E6F10-EC6D-48F9-B3B8-15505499A5AFQ36304063-227E7817-88E3-435F-B009-F4205C21FF04Q36715015-204EB673-C4D4-4AFC-8F94-DF05CEEF65E3Q36875566-5B9E3E73-D7A9-4FBC-BC22-AF5E06EFC869Q37800481-43424D3F-94B5-4BF7-BFF2-59FA5905B840Q38021389-89CA4BF5-F53C-4372-82A8-180F546B53AFQ38161920-CD59273C-531D-48C7-AA3F-2F5F2295E558Q38228728-A4139117-CC21-49F2-9F6D-E952376B665FQ38558706-EC239F90-2DC4-473F-A002-52605241978AQ38710744-08D554B5-E01E-4BFE-969A-4EDB60B39EF0Q39001743-13CDC53F-011F-4F24-B38A-12654D398E7BQ39346865-CB69DE0C-8D3A-4A69-8341-C846CB5776A0Q41872428-E1D43645-759C-4B1E-AC68-8FE72D5ED782Q41946984-8C8265DF-FF72-4EC6-B581-296F2AC41A04Q42663678-C19F072F-41B9-436E-8E02-106F0E7D1F09Q43588238-3808DAB6-3764-4945-8E9E-70E00468535DQ47441440-2F2B60D2-3E15-495E-8DC4-B20089C572C3Q47628566-286F01BB-1F92-4067-BD4E-28F5612C02A1Q47960020-260A1F1F-D415-4917-BDC1-B7D7780B65B9Q48060040-B8C5990E-36F8-47D2-8626-AD108A8DF261Q48154223-5FC162E7-3EAB-45A3-B820-6E342AEC9B09Q48383074-98D9DC93-174A-44BA-A7CE-9542CD4182B1Q48536821-0EC3B561-A967-4AAD-86C8-C36CE0005C4AQ48565555-FFE08B92-3EFA-4343-B911-B118F80F8A8EQ49780236-7E17C72B-5435-4E5D-A11D-A0E1BC709890
P2860
Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mapping the EORTC QLQ C-30 ont ...... thout generic preference data.
@ast
Mapping the EORTC QLQ C-30 ont ...... thout generic preference data.
@en
type
label
Mapping the EORTC QLQ C-30 ont ...... thout generic preference data.
@ast
Mapping the EORTC QLQ C-30 ont ...... thout generic preference data.
@en
prefLabel
Mapping the EORTC QLQ C-30 ont ...... thout generic preference data.
@ast
Mapping the EORTC QLQ C-30 ont ...... thout generic preference data.
@en
P1433
P1476
Mapping the EORTC QLQ C-30 ont ...... thout generic preference data.
@en
P2093
Lynda McKenzie
Marjon van der Pol
P304
P356
10.1111/J.1524-4733.2008.00405.X
P577
2008-07-11T00:00:00Z